Express Pharma

10th anniversary edition of UBM India’s CPhI and P-MEC India 2016, concludes in Mumbai

1

The event saw participation from 1,300 exhibitors, 100-plus countries with over 40,000 attendees

The Indian pharmaceutical industry saw the launch of the 10th anniversary edition of UBM India’s signature event, CPhI and P-MEC India 2016, one of the world’s leading pharma networking expos. This year’s edition of CPhI and P-MEC expo was held between November 21 and 23 in Mumbai – for the first time, at two concurrent venues – The Bombay Exhibition Centre (BEC) while it also made its debut at the MMRDA Grounds, Bandra Kurla Complex (BKC).

This year’s marquee event saw more than 1,300 exhibitors, a 100-plus countries’ participation and above 40,000 attendees. While BEC had traditional participants for CPhI and P-MEC; the concurrent venue at MMRDA Grounds, BKC also included participants for ICSE and BioPh.

The inauguration of CPhI-P-MEC 2016 were held parallely at both the venues in the presence of an august gathering of industry leaders including Dr PV Appaji, Director General, Pharmexcil, Ravi Uday Bhaskar, Additional Executive Director, Pharmexcil and Satish Wagh, Vice Chariman, Chemexcil and CMD Supriya Lifesciences; among others.

UBM India previously launched the India Pharma Week (IPW), an attractive platter of ten trend-setting events that got off to a flying start on November 17, prior to the CPhI and P-MEC expo. Focusing on the pillars of business, knowledge, leadership, innovation, recognition and networking in the pharma domain, the IPW included a Pre-Connect Congress; Women in Pharma – Power Breakfast; the India Pharma Awards; Networking Evening; Pharma Leaders’ Golf; a closed door CEO Roundtable and many more activities. The IPW transformed the CPhI and P-MEC exhibition from a wall-bound show to one with considerable intellectual value addition.

Originating from CPhI Worldwide, the CPhI and P-MEC India was first introduced in 2006. Today, it has become South Asia’s leading pharma meeting place, covering every step of the supply chain, from drug discovery to finished dosage. CPhI India is an industry platform encompassing CROs, CMOs and manufacturers of API, generics, excipients and drug formulation, fine chemicals, biosimilars, finished formulations, lab chemicals and biotechnology. P-MEC, on the other hand, had manufacturers of pharma machinery and equipment, analytical equipment, automation and robotics, packaging equipment and supplies, plant/ facility equipment, automation and controls, processing equipment, RFID, tableting/ capsule fillers, clean room equipment, filling equipment and laboratory products.

The show has grown exponentially over the years, with domestic and foreign exhibitors and visitors engaging over significant levels of business. This year, the expo comprised exciting facets such as the Supplier-Finder Desk (a digital floor plan that enabled visitors find exhibitors based on services or company names), Innovation Gallery (an arena where participating pharma companies were encouraged to showcase innovations on an international platform) and Exhibitor Showcase (a platform where exhibitors demonstrated how their new product launches are going to be efficacious).

The key companies exhibiting in the 2016 edition at CPhI were Hetero; Nectar Lifesciences; Alembic Pharmaceuticals; Glenmark Pharmaceuticals and Aurobindo Pharma, among others. On the other hand, some of the leading companies such as ACG Worldwide; Shimadzu Analytical; Gansons; Fette and Accupack Engineering will exhibited at P-MEC.

Yogesh Mudras, MD, UBM India said, “CPhI and P-MEC India 2016 is perfectly placed to provide a most comprehensive industry platform for every company that deals with pharmaceuticals in India. With it completing a decade in the industry, the expo gave us time to look back, revaluate, and move ahead. He added, “For the future, we believe that India has a strong potential to become a hub for biopharma innovation. The time has come for it to emerge as an innovator nation in this sector and play a leading role in collaborative research in bio pharma.”

Datta Nadkarni, CMO, Verayo, said, “The CPhI-P-MEC exhibition I’m sure was a tremendous success for all participants. It most certainly was for our company Verayo of the US, makers of ‘Physically Unclonable’ chips, which can be used in product authentication, track n trace with geo-positioning, and gather big data on the whole supply-chain – and readable with an NFC-enabled smartphone by anyone, anywhere worldwide. It gave us a chance to meet a lot of potential partners at the show and reconnect with friends in the pharma/ related industries. The show is a great ‘one stop shop’ to meet and discuss business, and explore strategic alliances or commercial opportunities all at one place. I think organisers should have an application to be able to search different companies by product and by booth no, marked on a map of the exhibit halls.”

EP News Bureau

Comments are closed.